Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ST13P13, or suppression of tumorigenicity 13 (colon carcinoma) (Hsp70 interacting protein) pseudogene 13, is a non-functional, non-coding pseudogene related to the ST13 gene, which encodes an adaptor protein involved in heat shock protein complex assembly and tumor suppression. The pseudogene does not produce protein and has no established biological or therapeutic function. The functional ST13 gene serves roles in assembly of chaperone complexes (notably Hsp70/Hsp90) and may act as a tumor suppressor, but these features do not apply to ST13P13[1][3]. The term "pseudogene" refers to a DNA sequence similar to a functional gene but typically non-functional due to mutations or lack of regulatory elements; as such, pseudogenes are not considered therapeutic targets in drug discovery or biomedical research[1][3]. If you intended to find information about the functional gene (ST13, Hsp70 interacting protein), that is a separate entry, and would be considered a potential target, but "ST13P13" specifically refers to a pseudogene[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Suppression of tumorigenicity 13 (colon carcinoma) (Hsp70 interacting protein) pseudogene 13 (ST13P13).